Artivion (AORT) Return on Capital Employed Growth (3y) (2014 - 2026)
Artivion (AORT) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.27 Bn | 175.98 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 128.81 Bn | 125.93 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 108.63 Bn | 99.41 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.84 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 1,318.00 |
| 7 | GE HealthCare Technologies | 28.31 Bn | 26.03 Bn | 1.98 Bn | -247.00 |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.35 Bn | 2.07 Bn | - |
| 10 | Artivion | 1.26 Bn | 1.21 Bn | 75.45 Mn | 463.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 463.00 |
| Dec 31, 2025 | 350.00 |
| Sep 30, 2025 | 440.00 |
| Jun 30, 2025 | 78.00 |
| Mar 31, 2025 | 101.00 |
| Dec 31, 2024 | 426.00 |
| Sep 30, 2024 | 355.00 |
| Jun 30, 2024 | 347.00 |
| Mar 31, 2024 | 401.00 |
| Dec 31, 2023 | 45.00 |
| Sep 30, 2023 | 32.00 |
| Jun 30, 2023 | -32.00 |
| Mar 31, 2023 | -230.00 |
| Dec 31, 2022 | -219.00 |
| Sep 30, 2022 | -396.00 |
| Jun 30, 2022 | -133.00 |
| Mar 31, 2022 | -165.00 |
| Dec 31, 2021 | -67.00 |
| Sep 30, 2021 | 140.00 |
| Jun 30, 2021 | 65.00 |